ZA901973B - Genetic units for inhibiting the function of rna - Google Patents

Genetic units for inhibiting the function of rna

Info

Publication number
ZA901973B
ZA901973B ZA901973A ZA901973A ZA901973B ZA 901973 B ZA901973 B ZA 901973B ZA 901973 A ZA901973 A ZA 901973A ZA 901973 A ZA901973 A ZA 901973A ZA 901973 B ZA901973 B ZA 901973B
Authority
ZA
South Africa
Prior art keywords
rna
units
inhibiting
genetic
unit
Prior art date
Application number
ZA901973A
Other languages
English (en)
Inventor
Hartmut Dr Beug
Beug Dr Hartmut
Max L Dr Birnstiel
L Birnstiel Dr Max
Matthew Dr Cotten
Cotten Dr Matthew
Ernst Dr Wagner
Wagner Dr Ernst
Harald Kandolf
Kandolf Harald
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA901973B publication Critical patent/ZA901973B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA901973A 1989-03-16 1990-03-15 Genetic units for inhibiting the function of rna ZA901973B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT60989 1989-03-16

Publications (1)

Publication Number Publication Date
ZA901973B true ZA901973B (en) 1991-11-27

Family

ID=3495118

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA901973A ZA901973B (en) 1989-03-16 1990-03-15 Genetic units for inhibiting the function of rna

Country Status (20)

Country Link
EP (1) EP0387775B1 (fr)
JP (1) JP3330930B2 (fr)
KR (1) KR900014591A (fr)
AT (1) ATE140961T1 (fr)
AU (1) AU637354B2 (fr)
CA (1) CA2012312C (fr)
DD (1) DD297838A5 (fr)
DE (1) DE59010432D1 (fr)
DK (1) DK0387775T3 (fr)
ES (1) ES2090049T3 (fr)
FI (1) FI105103B (fr)
GR (1) GR3020935T3 (fr)
HU (2) HU215187B (fr)
IE (1) IE74850B1 (fr)
IL (1) IL93754A (fr)
NO (1) NO306623B1 (fr)
NZ (1) NZ232917A (fr)
PT (1) PT93440B (fr)
RU (1) RU2136751C1 (fr)
ZA (1) ZA901973B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471796A4 (en) * 1989-05-10 1993-05-05 Sloan Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
DE4091533T (fr) * 1989-08-31 1992-01-30
JP2507895B2 (ja) * 1989-12-19 1996-06-19 工業技術院長 リボザイムの新規合成系
ATE150789T1 (de) * 1990-06-19 1997-04-15 Gene Shears Pty Ltd Endonukleasen
US6008343A (en) * 1990-06-19 1999-12-28 Gene Shears Pty. Ltd. Nucleotide based endonucleases
EP0552178B1 (fr) 1990-10-12 1997-01-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Ribozymes modifies
DE4104186A1 (de) * 1991-02-12 1992-08-13 Genentech Inc Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe
FR2687411A1 (fr) * 1992-02-13 1993-08-20 Nice Sophia Antipolis Universi Vecteur comportant un gene viral transcrit par l'arn polymerase iii, et procede de production intracellulaire d'arn.
WO1993022433A2 (fr) * 1992-04-28 1993-11-11 Frank Andreas Harald Meyer Medicament permettant de traiter l'homme, les animaux et les plantes par therapie genetique, dans le but notamment de bloquer la proliferation de virus et les carcinogenes et procede de fabrication dudit medicament
US5989906A (en) * 1992-05-14 1999-11-23 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting P-glycoprotein (mdr-1-gene)
CA2135499A1 (fr) * 1992-05-14 1993-11-25 James D. Thompson Methode et reagent pour l'inhibition de la cancerogenese
US5610052A (en) * 1992-08-26 1997-03-11 Ribozyme Pharmaceuticals Inc. Enzymatic RNA with activity to ras
CA2114312A1 (fr) * 1992-05-27 1993-12-09 John J. Rossi Molecules chimeriques arnt-ribozyme
US5827935A (en) * 1992-05-27 1998-10-27 City Of Hope Chimeric tRNAlys -ribozyme molecules
HUT71929A (en) * 1992-06-29 1996-02-28 Gene Shears Pty Ltd Nucleic acids and methods of use thereof for controlling viral pathogens
AU5968994A (en) * 1992-12-16 1994-07-04 Johanna E. Bergmann Agents for the prevention and treatment of human alzheimer's disease
DE69333216T2 (de) * 1993-07-06 2004-06-24 Université de Nice-Sophia Antipolis Vektor, enthält ein bei ARN-Polymerase-III transcriptes Virus-Gen
US5837503A (en) * 1993-07-07 1998-11-17 Universite De Nice-Sophia-Antipolis Vector containing viral gene transcribed by RNA polymerase III and methods for use
US5817635A (en) * 1993-08-09 1998-10-06 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
CA2157015A1 (fr) * 1994-01-24 1995-07-27 John J. Rossi Co-localisation d'une molecule cible et de ses inhibiteurs
DE4424761C1 (de) * 1994-07-04 1995-06-08 Max Planck Gesellschaft Expressionskassette für die Antisense- und die Ribozym-Expression
AU708995B2 (en) 1995-06-07 1999-08-19 Gene Shears Pty. Limited Optimized minizymes and miniribozymes and uses thereof
FR2755976B1 (fr) 1996-11-15 1999-01-15 Idm Immuno Designed Molecules Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
US6057156A (en) * 1997-01-31 2000-05-02 Robozyme Pharmaceuticals, Inc. Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
AU1187099A (en) * 1997-10-21 1999-05-10 Ribozyme Pharmaceuticals, Inc. Peptide bond formation using nucleic acid catalysts
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
JP4187413B2 (ja) 1998-03-20 2008-11-26 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション 遺伝子発現の制御
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO2000044914A1 (fr) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1229134A3 (fr) 2001-01-31 2004-01-28 Nucleonics, Inc Utilisation de l'inhibition post-transcriptionnelle pour l'identification des séquences d'acides nucléiques qui modifient la fonction d'une cellule
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods

Also Published As

Publication number Publication date
HU901584D0 (en) 1990-06-28
DE59010432D1 (de) 1996-09-05
HU211868A9 (en) 1995-12-28
GR3020935T3 (en) 1996-12-31
HUT54206A (en) 1991-01-28
EP0387775B1 (fr) 1996-07-31
CA2012312C (fr) 2001-08-14
KR900014591A (ko) 1990-10-24
FI901296A0 (fi) 1990-03-15
IL93754A0 (en) 1990-12-23
NO901213L (no) 1990-09-17
NO901213D0 (no) 1990-03-15
AU5130190A (en) 1990-11-01
DD297838A5 (de) 1992-01-23
AU637354B2 (en) 1993-05-27
IL93754A (en) 1995-12-31
EP0387775A1 (fr) 1990-09-19
IE900931L (en) 1990-09-16
FI105103B (fi) 2000-06-15
ES2090049T3 (es) 1996-10-16
DK0387775T3 (da) 1996-11-04
PT93440A (pt) 1990-11-07
RU2136751C1 (ru) 1999-09-10
JP3330930B2 (ja) 2002-10-07
CA2012312A1 (fr) 1990-09-16
NO306623B1 (no) 1999-11-29
ATE140961T1 (de) 1996-08-15
PT93440B (pt) 2001-07-31
IE74850B1 (en) 1997-08-13
NZ232917A (en) 1997-07-27
HU215187B (hu) 1998-10-28
JPH03130080A (ja) 1991-06-03

Similar Documents

Publication Publication Date Title
AU637354B2 (en) Genetic units for inhibiting the function of rna
WO1996019568A3 (fr) Analogues de ribozymes stabilises
Durand et al. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX
HU9501963D0 (en) 7-deazapurine modified oligonucleotides
ATE189264T1 (de) Chimärisches oligonukleotid und dessen verwendung zur herstellung von nukleinsäure-transkripten
AU4072089A (en) Inhibition of htlv-iii by exogenous oligonucleotides
PT731835E (pt) Oligonucleotidos anti-sentido possuindo actividade inibidora de tumorigenicidade
UA42675C2 (uk) Спосіб активації гена, що в нормі транскрипційно мовчить, з геному еукаріотичної клітинної лінії, спосіб модифікації характеристик експресії гена з геному еукаріотичної клітинної лінії, диференційована еукаріотична клітинна лінія (варіанти), днк-конструкт
AU7345694A (en) A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
HUP0103465A2 (hu) A VEGF expressziójának gátlására szolgáló rövid oligonukleotidok
EP0321196A3 (fr) Activateur de transcription du gène 780 d
EP0424473A4 (en) Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
DE69921609D1 (de) Ribozymale nukleinsäure die ccr5 oder cxcr4 schneiden
Hatta et al. Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides
AU6144294A (en) Plant virus resistance conferring polyribozyme and resistant plants producing same
WO2000017346A2 (fr) Molecules hybridantes en epingle a cheveux servant a moduler l'expression genique
EP0592685A4 (fr) Vegetal resistant a au moins deux virus et sa preparation.
Remington Attenuation as a general mechanism for the regulation of differential gene transcription in eukaryotes
EP0691853A4 (fr) OLIGONUCLEOTIDES ANTISENS INTERFERANT AVEC L'ACTIVITE DE COIFFE DE L'ARNm ET INHIBANT LA TRADUCTION
WO1995025801A3 (fr) Replicon viral
Richardson et al. Identification of upstream sequence components of rho-dependent transcription terminators.
AU3956100A (en) Rna polymerase i transcription factor tif-ia
UA19318A (uk) СПОСІБ ОДЕРЖАHHЯ ЛЮДСЬКОЇ МnО2-ДИСМУТАЗИ
Cho The Regulation of Bacteriophage N4 Transcription
Sugisaki Kinetoplast Minicircles Carrying Guide RNA Genes of Leishmania tarentolae (RESEARCH FACILITY OF NUCLEIC ACIDS)